Milestone Pharmaceuticals Inc. (34)
Browse by Contract Category
Contracts
-
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on March 24, 2022)
-
Employment Agreement, dated February 15, 2022 between David Bharucha, M.D., Ph.D. and Milestone Pharmaceuticals USA, Inc
(Filed With SEC on February 16, 2022)
-
License and Collaboration Agreement by and among the Company and Ji Xing Pharmaceuticals, Limited, dated May 15, 2021
(Filed With SEC on August 11, 2021)
-
Form of Pre-Funded Warrants to Purchase Common Shares
(Filed With SEC on August 11, 2021)
-
The Non-employee Director Compensation Policy, as amended
(Filed With SEC on May 17, 2021)
-
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on March 29, 2021)
-
The Non-employee Director Compensation Policy, as amended
(Filed With SEC on November 13, 2020)
-
Form of Pre-Funded Warrant
(Filed With SEC on October 26, 2020)
-
Underwriting Agreement, dated October 22, 2020, by and among the Company, Jefferies LLC and Piper Sandler & Co
(Filed With SEC on October 26, 2020)
-
Open Market Sale AgreementSM, dated July 29, 2020, by and between Milestone Pharmaceuticals Inc. and Jefferies LLC
(Filed With SEC on July 29, 2020)
-
Securities Purchase Agreement dated July 22, 2020
(Filed With SEC on July 23, 2020)
-
Form of Pre-Funded Warrant to Purchase Common Shares
(Filed With SEC on July 23, 2020)
-
Amending Agreement, dated June 4, 2020, between the Company and Francis Plat
(Filed With SEC on June 9, 2020)
-
First Amendment to Employment Agreement, dated June 4, 2020, between the Company and Amit Hasija
(Filed With SEC on June 9, 2020)
-
First Amendment to Amended and Restated Employment Agreement, dated June 4, 2020, between the Company and Joseph Oliveto
(Filed With SEC on June 9, 2020)
-
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
(Filed With SEC on March 6, 2020)
-
Employment Agreement, dated September 9, 2019, between the Company and Amit Hasija
(Filed With SEC on September 10, 2019)
-
Form of Common Share Certificate of the Registrant
(Filed With SEC on April 29, 2019)
-
Employment Agreement between Timothy L. Maness and Milestone Pharmaceuticals USA, Inc
(Filed With SEC on April 29, 2019)
-
Amended and Restated Employment Agreement between Joseph Oliveto and Milestone Pharmaceuticals USA, Inc
(Filed With SEC on April 29, 2019)
-
Amended and Restated Employment Agreement between Philippe Douville and Milestone Pharmaceuticals Inc
(Filed With SEC on April 29, 2019)
-
Amended and Restated Employment Agreement between Francis Plat and Milestone Pharmaceuticals Inc
(Filed With SEC on April 29, 2019)
-
Amended and Restated Employment Agreement between Lorenz Muller and Milestone Pharmaceuticals USA, Inc
(Filed With SEC on April 29, 2019)
-
Form of Underwriting Agreement
(Filed With SEC on April 29, 2019)
-
Form of 2019 Equity Incentive Plan
(Filed With SEC on April 12, 2019)
-
Form of Indemnity Agreement
(Filed With SEC on April 12, 2019)
-
Third Amended and Restated Stock Option Plan
(Filed With SEC on April 12, 2019)
-
Third Amended and Restated Registration Rights Agreement, by and among the Registrant and certain of its shareholders, dated October 15, 2018
(Filed With SEC on April 12, 2019)
-
Form of United States Stock Option Grant Notice and Stock Option Agreement under the 2019 Equity Incentive Plan
(Filed With SEC on April 12, 2019)
-
Form of United States Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2019 Equity Incentive Plan
(Filed With SEC on April 12, 2019)
-
Form of Canadian Stock Option Grant Notice and Option Agreement under the 2019 Equity Incentive Plan
(Filed With SEC on April 12, 2019)
-
Form of Canadian Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement under the 2019 Equity Incentive Plan
(Filed With SEC on April 12, 2019)
-
2019 Employee Stock Purchase Plan
(Filed With SEC on April 12, 2019)
-
Form of Award and Grant Notices under the Third Amended and Restated Stock Option Plan
(Filed With SEC on April 12, 2019)